Rentschler, CGT Catapult, and Refeyn Sign AAV Gene Therapy Agreement
Rentschler Biopharma agreed to collaborate with Cell and Gene Therapy Catapult and Refeyn to develop and apply novel process analytical technologies (PAT) to improve the...
Automotive and Car
